Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
The Standards of Reporting of Neurological Disorders (STROND) checklist: Application to multiple sclerosis.
Epstein-Barr virus neuraxis infection as a trigger for central nervous system demyelinating processes: a case report.
Potential anti-tumor effects of FTY720 associated with PP2A activation: a brief review.
Recruitment of participants to a multiple sclerosis trial: The CombiRx experience.
Biomarker Detection in Association Studies: Modeling SNPs Simultaneously via Logistic ANOVA.
Pregnancy and multiple sclerosis.
Blockade of CD127 Exerts a Dichotomous Clinical Effect in Marmoset Experimental Autoimmune Encephalomyelitis.
Ginsenoside Rd ameliorates experimental autoimmune encephalomyelitis in C57BL/6 mice.
Ion Channels in Neurological Disorders.
CXCL13 antibody for the treatment of autoimmune disorders.
Retinal Damage and Vision Loss in African-American Multiple Sclerosis Patients.
Evidence for a multiple sclerosis epidemic?
Pharmacodynamic Consequences of Administration of VLA-4 Antagonist CDP323 to Multiple Sclerosis Subjects: A Randomized, Double-Blind Phase 1/2 Study.
Disease-modifying therapies and infectious risks in multiple sclerosis.
Iron deposition in the precentral grey matter in patients with multiple sclerosis: A quantitative study using susceptibility-weighted imaging.
Longitudinal fMRI studies: Exploring brain plasticity and repair in MS.
Next-generation sequencing in understanding complex neurological disease.
Multiple Sclerosis: Current Knowledge and Future Outlook.
[Cognitive deficits and dementia in patients with multiple sclerosis: status quo and open questions].
Age-associated changes in rat immune system: Lessons learned from experimental autoimmune encephalomyelitis.
Autoimmune Aquaporin-4 Myopathy in Neuromyelitis Optica Spectrum.
[Ultrahigh field MRI in context of neurological diseases.]
Serum Biomarker gMS-Classifier2: Predicting Conversion to Clinically Definite Multiple Sclerosis.
Change of Th17 Lymphocytes and Treg/Th17 in Typical and Atypical Optic Neuritis.
Vital role of specialist MS nurses recognised in proposed guideline.
Pages
« first
‹ previous
…
342
343
344
345
346
347
348
349
350
…
next ›
last »